Drug, Device, Digital: Reimagined Healthcare?



Digital solutions are increasingly part of new healthcare standards. However, the solutions available today are very widespread and not readily available to healthcare professionals and their patients. For that reason, the successful adoption of digital health needs better integration across patients and products i.e. the device and the drug. The integration and provision of end-to-end products and services achieves this and facilitates communication to those involved in the continuum of care. This webinar will be of interest to decision makers in digital health within the lifesciences industry.

In this online discussion, you will:

  • Understand the benefits of integrated digital health solutions
  • Discover the latest trends digital healthcare
  • Meet expert Pharma Executives in digital health

The Speakers

Aurore Beaume, Senior Vice President Global Business Development – Voluntis, an Aptar Pharma Company

CĂ©line Ulmann, Head of R&D Digital, Almirall

Stacy Feld, Head J&J Innovation West North America, Australia & New Zealand, Johnson & Johnson

Josh Raysman, Vice President, Digital Innovation Lab, Pfizer

Drug Device Digital Aptar Pharma Voluntis

Now available On-Demand!

  • * Required information The mandatory fields above are necessary for Voluntis to process your contact request. If you do not fill them in, your request cannot be processed. To find out more about the use of your personal data and how to exercise your rights, please consult the Privacy Policy
  • This field is for validation purposes and should be left unchanged.